Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models-Reference-Cited by-同舟云学术

Avoiding and Identifying Errors and Other Threats to the Credibility of Health Economic Models

Published:2014-07-16 Issue:10 Volume:32 Page:967-979
ISSN:1170-7690
Container-title:PharmacoEconomics
language:en
Short-container-title:PharmacoEconomics

Author:

Tappenden Paul,Chilcott James B.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40273-014-0186-2.pdf

Reference42 articles.

1. Drummond M, Sculpher M, Torrance G, O’Brien B, Stoddart G. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.

2. Sorenson C. Use of comparative effectiveness research in drug coverage and pricing decisions: a six-country comparison. Commonw Fund. 2010;91:1–14.

3. Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. 1st ed. Oxford: Oxford University Press; 2006.

4. Eddy D. Technology assessment: the role of mathematical modeling. In: National Research Council, editor. Assessing Medical Technology. Washington DC: National Academies; 1985.

5. Kaltenthaler E, Tappenden P, Paisley S. Reviewing the evidence to inform the population of cost-effectiveness models within health technology assessments. Value Health. 2013;16(5):830–6.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The UK resuscitative endovascular balloon occlusion of the aorta in trauma patients with life-threatening torso haemorrhage: the (UK-REBOA) multicentre RCT;Health Technology Assessment;2024-09

2. The effects and safety of testosterone replacement therapy for men with hypogonadism: the TestES evidence synthesis and economic evaluation;Health Technology Assessment;2024-08

3. Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis;Health Technology Assessment;2024-08

4. A structured process for the validation of a decision-analytic model: application to a cost-effectiveness model for risk-stratified national breast screening;Applied Health Economics and Health Policy;2024-05-16

5. Cost‐effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels;Andrology;2024-01-17